Third Harmonic Bio
Company Details
Status: Private
Employees: 11-50
Location:
1700 Montgomery St, Suite 210, San Francisco, California 94111, US
Type:
sample
Technology:
sample
About: Third Harmonic Bio is a clinical-stage biopharmaceutical company developing a highly selective, oral KIT inhibitor for treatment of dermal, respiratory and gastrointestinal inflammatory diseases. KIT is a cell surface receptor that acts as the master survival and functional regulator of mast cells, which are immune cells concentrated at the body's interfaces with the external environment and that act as the key mediator of the inflammation associated with mast-cell mediated inflammatory diseases. By inhibiting KIT, we believe we can provide broad symptomatic relief to patients with a range of disorders, including chronic spontaneous urticaria and severe asthma.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Third Harmonic Bio | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.